|
Market Closed -
Nasdaq
16:00:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 106.12 USD | -1.39% |
|
+5.41% | +57.68% |
| Market Cap | 12.04B 10.31B 9.62B 8.83B 16.59B 1,152B 16.92B 114B 44.5B 578B 45.22B 44.24B 1,912B | P/E 2026 * |
14.7x | P/E 2027 * | 11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 13.39B 11.46B 10.7B 9.81B 18.44B 1,281B 18.8B 127B 49.46B 642B 50.27B 49.18B 2,125B | EV / Sales 2026 * |
7.22x | EV / Sales 2027 * | 6.03x |
| Free-Float |
98.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -1.39% | ||
| 1 week | +5.41% | ||
| Current month | +28.57% | ||
| 1 month | +37.66% | ||
| 3 months | +53.84% | ||
| 6 months | +49.51% | ||
| Current year | +57.68% |
| 1 week | 98.58 |  | 107.96 |
| 1 month | 76.82 | | 107.96 |
| Current year | 61.32 | | 107.96 |
| 1 year | 61.22 | | 107.96 |
| 3 years | 32.83 | | 107.96 |
| 5 years | 29.85 | | 107.96 |
| 10 years | 8.18 | | 107.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 | Fiscal year | Chief Executive Officer | 60,000 | 0.0506% | ||
| 8/10/26 | Sell | Director | -1,626 | 0.0014% | ||
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | +5.41% | +49.19% | +145.31% | 12.04B | |
| -2.11% | +9.92% | +75.99% | +36.44% | 368B | |
| -0.72% | +0.33% | +23.76% | -13.42% | 70.1B | |
| -1.85% | -0.12% | -2.05% | -0.25% | 8.66B | |
| +1.41% | -1.26% | -10.82% | 0.00% | 4.86B | |
| +4.77% | +1.09% | -26.39% | +19.47% | 4.46B | |
| +8.85% | -18.65% | -15.25% | +23.50% | 3.48B | |
| -2.25% | +0.64% | +11.18% | +53.21% | 2.76B | |
| +1.95% | -2.83% | -8.04% | -4.20% | 2.17B | |
| +3.78% | -3.91% | -22.29% | +36.76% | 1.97B | |
| Average | +1.24% | -0.79% | +7.53% | +29.68% | 47.81B | |
| Weighted average by Cap. | -1.66% | +7.46% | +62.58% | +30.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85B 1.59B 1.48B 1.36B 2.55B 177B 2.6B 17.57B 6.85B 88.89B 6.96B 6.81B 294B | 2.05B 1.76B 1.64B 1.5B 2.82B 196B 2.88B 19.43B 7.58B 98.34B 7.7B 7.53B 326B |
| Net income | 869M 744M 694M 637M 1.2B 83.13B 1.22B 8.23B 3.21B 41.66B 3.26B 3.19B 138B | 1.07B 914M 853M 783M 1.47B 102B 1.5B 10.12B 3.94B 51.21B 4.01B 3.92B 170B |
| Net Debt | 1.34B 1.15B 1.07B 985M 1.85B 129B 1.89B 12.74B 4.96B 64.45B 5.05B 4.94B 213B | 320M 274M 255M 234M 440M 30.57B 449M 3.03B 1.18B 15.32B 1.2B 1.17B 50.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | US$106.12 | -1.39% | 1,577,789 |
| 26-08-19 | US$107.62 | +2.60% | 2,539,548 |
| 26-08-18 | US$104.89 | +1.83% | 1,955,274 |
| 26-08-17 | US$103.00 | +4.40% | 2,199,601 |
| 26-08-14 | US$98.66 | -2.00% | 1,659,274 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
